You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 142 No. 8, August 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Correction
 This Article
 •PDF of this Correction
 •Original article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Dermatology, Other
 •Alert me on articles by topic

Errors in Text and Acknowledgment in: Randomized Controlled Trial of Adjuvant Oral Dexamethasone Pulse Therapy in Pemphigus Vulgaris: PEMPULS Trial

Arch Dermatol. 2006;142:1014.

Errors in Text and Acknowledgment. In the Study by Mentink et al titled "Randomized Controlled Trial of Adjuvant Oral Dexamethasone Pulse Therapy in Pemphigus Vulgaris: PEMPULS Trial," published in the May issue of the ARCHIVES (2006;142:570-576), the number of oral doses was inadvertently misstated in the "Study Protocol" subsection of the "Methods" section on page 571. In the second paragraph, the fourth sentence should have read as follows: "During pulse visits, 6 oral tablets of 50 mg of dexamethasone, or 6 tablets of placebo (which were both specially produced to be identical in taste and smell and were tested for this study)18 were given on 3 consecutive days every 4 weeks." In addition, the academic degree for Dédée Murrell, in the last line of the Acknowledgment on page 576, should have been listed as MD. Online versions of this article on the Archives of Dermatology Web site were corrected on May 23, 2006.







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.